Subsequently, Zhao et al. showed BOs from AD patients carrying APOE4 increased levels of Aβ and phosphorylated Tau, and exacerbated neuronal cell apoptosis and synapse loss, confirming that APOE4-mediated degenerative pathways contributing to AD pathogenesis [97]. The gene discussed is MAPT; the disease is Alzheimer disease.